Literature DB >> 20215508

Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.

Isaia Barbieri1, Sara Pensa, Tania Pannellini, Elena Quaglino, Diego Maritano, Marco Demaria, Alessandra Voster, James Turkson, Federica Cavallo, Christine J Watson, Paolo Provero, Piero Musiani, Valeria Poli.   

Abstract

The transcription factor signal transducer and activator of transcription 3 (STAT3) is constitutively activated in tumors of different origin, but the molecular bases for STAT3 requirement are only partly understood. To evaluate the contribution of enhanced Stat3 activation in a controlled model system, we generated knock-in mice wherein a mutant constitutively active Stat3C allele replaces the endogenous wild-type allele. Stat3C could enhance the tumorigenic power of the rat Neu oncogene in mouse mammary tumor virus (MMTV)-Neu transgenic mice, triggering the production of earlier onset, more invasive mammary tumors. Tumor-derived cell lines displayed higher migration, invasion, and metastatic ability and showed disrupted distribution of cell-cell junction markers mediated by Stat3-dependent overexpression of the COOH terminal tensin-like (Cten) focal adhesion protein, which was also significantly upregulated in Stat3C mammary tumors. Importantly, the proinflammatory cytokine interleukin-6 could mediate Cten induction in MCF10 cells in an exquisitely Stat3-dependent way, showing that Cten upregulation is a feature of inflammation-activated Stat3. In light of the emerging pivotal role of Stat3 in connecting inflammation and cancer, our identification of Cten as a Stat3-dependent mediator of migration provides important new insights into the oncogenic role of Stat3, particularly in the breast.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215508     DOI: 10.1158/0008-5472.CAN-09-2840

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  67 in total

1.  Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration.

Authors:  Marylynn Snyder; Xin-Yun Huang; J Jillian Zhang
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  STAT3 can serve as a hit in the process of malignant transformation of primary cells.

Authors:  M Demaria; S Misale; C Giorgi; V Miano; A Camporeale; J Campisi; P Pinton; V Poli
Journal:  Cell Death Differ       Date:  2012-03-09       Impact factor: 15.828

3.  Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.

Authors:  Joomin Lee; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2010-08-19       Impact factor: 4.944

Review 4.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

Review 5.  Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.

Authors:  Katherine A Leehy; Thu H Truong; Laura J Mauro; Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2017-04-23       Impact factor: 4.292

6.  Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.

Authors:  Amir Sonnenblick; Anat Shriki; E Galun; Jonathan H Axelrod; Hagit Daum; Yakir Rottenberg; Tamar Hamburger; Bela Mali; Tamar Peretz
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

7.  Breast cancer: the menacing face of Janus kinase.

Authors:  C J Watson; K Hughes
Journal:  Cell Death Differ       Date:  2014-02       Impact factor: 15.828

8.  A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers.

Authors:  Hong-Hee Won; Jong-Won Kim; Doheon Lee
Journal:  Hum Genet       Date:  2012-08-21       Impact factor: 4.132

9.  The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.

Authors:  Christian Senft; Margareth Polacin; Maike Priester; Volker Seifert; Donat Kögel; Jakob Weissenberger
Journal:  BMC Cancer       Date:  2010-09-14       Impact factor: 4.430

10.  Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis.

Authors:  Luke Martin McCaffrey; JoAnne Montalbano; Constantina Mihai; Ian G Macara
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.